Paxton-LLC is the first company in Egypt to raise awareness for central line care for oncology, dialysis & ICU patients. We have successfully introduced the complete
portfolio of critical ill patients in Egypt. Out of our aspiration to challenge the society’s most pressing health issues we went the extra mile to score a milestone in the
categories we are focusing on.
We have proudly built well established famous brands in Egypt like TauroPharm from Germany and Emodial from Italy. In 2013 Paxton-LLC launched baby and mother care products like Health point Zinc & Castor Cream, Health point Nappy Cream, Derma V10 Rescue oil and Derma V10 Lotion & Cream. We were also very concerned with the oral hygiene segment so we launched Health point Chlorhexidine
Alcohol & Alcohol free mouthwash.
Our Regulatory access and system is very strong which enabled us to collaborate with topnotch pharmaceutical companies abroad and help them access the Egyptian market through Paxton.
The products we offer are unique with almost no competition in the local market. We also managed to offer those products at cost efficient prices to clients which we consider as one of our biggest achievements as a company.
All our products are either manufactured in the USA or the EU which ensures their quality standards and is another strength we have at Paxton-LLC.
Notable Partnerships:
2012 | Tauropharm Gmbh | Germany
We are proudly the first company in town to adopt a strategy for central care line in Egypt since 2010.
2014 | Emodial s.r.l | Italy
2023 | Bluepharma Group | Portugal
We serve as Bluepharma’s partner in Egypt, leading the registration, institutional access, and distribution of its transplantation-focused pharmaceutical portfolio, ensuring availability across key transplant centers and hospitals nationwide.
2025 | Eumedica | Belgium
We are the exclusive distributor in Egypt for Tasonormin® (Beromun), a specialized treatment for soft tissue sarcoma. Our partnership ensures full regulatory compliance, reliable supply, and strong institutional presence for this critical oncology therapy.
2026 | AqVida GmbH | Germany
We act as AqVida’s strategic partner in Egypt for its oncology portfolio, delivering comprehensive regulatory, commercial, and supply chain support to ensure consistent access to advanced oncology therapies within the Egyptian healthcare sector.
